PL1771157T3 - Wielocząstkowa postać leku dla słabo rozpuszczalnych substancji czynnych oraz sposób wytwarzania tej postaci leku - Google Patents
Wielocząstkowa postać leku dla słabo rozpuszczalnych substancji czynnych oraz sposób wytwarzania tej postaci lekuInfo
- Publication number
- PL1771157T3 PL1771157T3 PL05758133T PL05758133T PL1771157T3 PL 1771157 T3 PL1771157 T3 PL 1771157T3 PL 05758133 T PL05758133 T PL 05758133T PL 05758133 T PL05758133 T PL 05758133T PL 1771157 T3 PL1771157 T3 PL 1771157T3
- Authority
- PL
- Poland
- Prior art keywords
- pharmaceutical dosage
- dosage form
- active agent
- multiparticle
- polymer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004036437A DE102004036437A1 (de) | 2004-07-27 | 2004-07-27 | Multipartikuläre Arzneiform für wenig lösliche Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform |
| PCT/EP2005/007427 WO2006010453A1 (de) | 2004-07-27 | 2005-07-08 | Multipartikuläre arzneiform für wenig lösliche wirkstoffe sowie ein verfahren zur herstellung der arzneiform |
| EP05758133A EP1771157B1 (de) | 2004-07-27 | 2005-07-08 | Multipartikuläre arzneiform für wenig lösliche wirkstoffe sowie ein verfahren zur herstellung der arzneiform |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1771157T3 true PL1771157T3 (pl) | 2008-08-29 |
Family
ID=35169905
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05758133T PL1771157T3 (pl) | 2004-07-27 | 2005-07-08 | Wielocząstkowa postać leku dla słabo rozpuszczalnych substancji czynnych oraz sposób wytwarzania tej postaci leku |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8273375B2 (pl) |
| EP (1) | EP1771157B1 (pl) |
| JP (1) | JP5455305B2 (pl) |
| KR (1) | KR101216750B1 (pl) |
| AT (1) | ATE388692T1 (pl) |
| BR (1) | BRPI0513904B8 (pl) |
| CA (1) | CA2570608C (pl) |
| DE (2) | DE102004036437A1 (pl) |
| ES (1) | ES2302209T3 (pl) |
| IL (1) | IL180943A (pl) |
| MX (1) | MX2007000955A (pl) |
| PL (1) | PL1771157T3 (pl) |
| SI (1) | SI1771157T1 (pl) |
| WO (1) | WO2006010453A1 (pl) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10332160A1 (de) * | 2003-07-15 | 2005-02-03 | Röhm GmbH & Co. KG | Multipartikuläre Arzneiform, enthaltend mucoadhaesiv formulierte Peptid- oder Protein-Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform |
| DE102004059792A1 (de) * | 2004-12-10 | 2006-06-14 | Röhm GmbH & Co. KG | Multipartikuläre Arzneiform, enthaltend mucoadhaesiv formulierte Nukleinsäure-Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform |
| DE102005007059A1 (de) | 2005-02-15 | 2006-08-24 | Röhm GmbH & Co. KG | Teilneutralisiertes anionisches (Meth)acrylat-Copolymer |
| US8048413B2 (en) | 2006-05-17 | 2011-11-01 | Helene Huguet | Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules |
| DE102006035549A1 (de) * | 2006-07-27 | 2008-01-31 | Evonik Röhm Gmbh | Arzneiform mit mindestens zweischichtiger Trennschicht |
| DE102007031697A1 (de) * | 2007-07-06 | 2009-01-08 | Walter Rau Neusser Öl und Fett AG | Kosmetische oder pharmazeutische Zubereitung |
| PL2538955T3 (pl) | 2010-02-25 | 2016-04-29 | Evonik Roehm Gmbh | Formulacja farmaceutyczna lub nutraceutyczna |
| US11974971B2 (en) | 2011-01-07 | 2024-05-07 | Anji Pharmaceuticals Inc. | Compositions and methods for treating metabolic disorders |
| US8796338B2 (en) | 2011-01-07 | 2014-08-05 | Elcelyx Therapeutics, Inc | Biguanide compositions and methods of treating metabolic disorders |
| ES2834986T3 (es) | 2011-01-07 | 2021-06-21 | Anji Pharma Us Llc | Terapias basadas en ligandos de receptores quimiosensoriales |
| US9211263B2 (en) | 2012-01-06 | 2015-12-15 | Elcelyx Therapeutics, Inc. | Compositions and methods of treating metabolic disorders |
| US11759441B2 (en) | 2011-01-07 | 2023-09-19 | Anji Pharmaceuticals Inc. | Biguanide compositions and methods of treating metabolic disorders |
| US9572784B2 (en) | 2011-01-07 | 2017-02-21 | Elcelyx Therapeutics, Inc. | Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk |
| US9532952B2 (en) | 2011-01-28 | 2017-01-03 | Physician's Seal, LLC | Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients |
| WO2012103411A2 (en) | 2011-01-28 | 2012-08-02 | Zx Pharma, Llc | Controlled-release melatonin composition and related methods |
| TR201808978T4 (tr) | 2011-02-11 | 2018-07-23 | Zx Pharma Llc | Çok partiküllü l-mentol formülasyonları ve ilgili yöntemler. |
| US8808736B2 (en) | 2011-02-11 | 2014-08-19 | Zx Pharma, Llc | Enteric coated multiparticulate controlled release peppermint oil composition and related methods |
| US8911780B2 (en) | 2011-02-11 | 2014-12-16 | Zx Pharma, Llc | Multiparticulate L-menthol formulations and related methods |
| BR112013028453B8 (pt) * | 2011-06-17 | 2022-07-05 | Evonik Roehm Gmbh | Uso de uma composição de revestimento, formas de dosagem farmacêuticas ou nutracêuticas gastrorresistentes, e composição do polímero do núcleo/invólucro |
| BR112014016810A8 (pt) | 2012-01-06 | 2017-07-04 | Elcelyx Therapeutics Inc | composições e métodos para tratamento de distúrbios metabólicos |
| JP2015503582A (ja) | 2012-01-06 | 2015-02-02 | エルセリクス セラピューティクス インコーポレイテッド | ビグアナイド組成物および代謝障害を治療する方法 |
| RS58325B1 (sr) | 2013-04-23 | 2019-03-29 | Zx Pharma Llc | Enterosolventno obloženi višečestični preparat sa proteinskom sub-oblogom |
| CN105188415A (zh) * | 2013-05-06 | 2015-12-23 | 帝斯曼知识产权资产管理有限公司 | 粉末状维生素e制剂 |
| US20160022644A1 (en) * | 2014-07-22 | 2016-01-28 | Tsu-I Catherine Wang | Oral Transmucosal Compositions Including Aromatase Inhibitors for Treating Female Infertility |
| WO2016077454A1 (en) * | 2014-11-11 | 2016-05-19 | Verdure Sciences | Stable solid lipid particle composition for improved bioavailability of lipophilic compounds for age-related diseases |
| WO2016210103A1 (en) * | 2015-06-26 | 2016-12-29 | Advanced Bionutrition Corporation | Composition for delivery of active agents to an animal |
| AU2019275409A1 (en) | 2018-05-24 | 2020-07-16 | Celanese Eva Performance Polymers Llc | Implantable device for sustained release of a macromolecular drug compound |
| CA3087238A1 (en) | 2018-05-24 | 2019-11-28 | Celanese EVA Performance Polymers Corporation | Implantable device for sustained release of a macromolecular drug compound |
| CN115154661A (zh) * | 2022-07-29 | 2022-10-11 | 广州莱度品牌管理有限公司 | 一种仿生角质膜的制备方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW209174B (pl) | 1991-04-19 | 1993-07-11 | Takeda Pharm Industry Co Ltd | |
| US5938990A (en) | 1994-07-01 | 1999-08-17 | Roche Vitamins Inc. | Encapsulation of oleophilic substances and compositions produced thereby |
| US20030017195A1 (en) * | 2001-07-20 | 2003-01-23 | Samir Mitragotri | Method for oral drug delivery |
| US7670627B2 (en) * | 2002-12-09 | 2010-03-02 | Salvona Ip Llc | pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients |
| DE10332160A1 (de) | 2003-07-15 | 2005-02-03 | Röhm GmbH & Co. KG | Multipartikuläre Arzneiform, enthaltend mucoadhaesiv formulierte Peptid- oder Protein-Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform |
| DE10353186A1 (de) | 2003-11-13 | 2005-06-16 | Röhm GmbH & Co. KG | Mehrschichtige Arzneiform, enthaltend eine in Bezug auf die Wirkstoffabgabe modulatorisch wirkende Substanz |
| DE10353196A1 (de) | 2003-11-13 | 2005-06-16 | Röhm GmbH & Co. KG | Mehrschichtige Arzneiform mit einer die Abgabe einer modulatorischen Substanz beeinflussenden Matrix |
| WO2005065654A2 (en) * | 2003-12-31 | 2005-07-21 | Alpharma, Inc. | Rosiglitazone formulations |
| US20040224019A1 (en) * | 2004-03-03 | 2004-11-11 | Adi Shefer | Oral controlled release system for targeted drug delivery into the cell and its nucleus for gene therapy, DNA vaccination, and administration of gene based drugs |
| DE102006035549A1 (de) | 2006-07-27 | 2008-01-31 | Evonik Röhm Gmbh | Arzneiform mit mindestens zweischichtiger Trennschicht |
-
2004
- 2004-07-27 DE DE102004036437A patent/DE102004036437A1/de not_active Withdrawn
-
2005
- 2005-07-08 EP EP05758133A patent/EP1771157B1/de active Active
- 2005-07-08 WO PCT/EP2005/007427 patent/WO2006010453A1/de active IP Right Grant
- 2005-07-08 AT AT05758133T patent/ATE388692T1/de active
- 2005-07-08 CA CA2570608A patent/CA2570608C/en active Active
- 2005-07-08 BR BRPI0513904A patent/BRPI0513904B8/pt active IP Right Grant
- 2005-07-08 US US11/572,720 patent/US8273375B2/en active Active
- 2005-07-08 DE DE502005003223T patent/DE502005003223D1/de active Active
- 2005-07-08 KR KR1020077002117A patent/KR101216750B1/ko active IP Right Grant
- 2005-07-08 SI SI200530221T patent/SI1771157T1/sl unknown
- 2005-07-08 ES ES05758133T patent/ES2302209T3/es active Active
- 2005-07-08 MX MX2007000955A patent/MX2007000955A/es active IP Right Grant
- 2005-07-08 JP JP2007522954A patent/JP5455305B2/ja active Active
- 2005-07-08 PL PL05758133T patent/PL1771157T3/pl unknown
-
2007
- 2007-01-25 IL IL180943A patent/IL180943A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL180943A0 (en) | 2007-07-04 |
| US20080166416A1 (en) | 2008-07-10 |
| SI1771157T1 (sl) | 2008-06-30 |
| ES2302209T3 (es) | 2008-07-01 |
| ATE388692T1 (de) | 2008-03-15 |
| MX2007000955A (es) | 2007-04-16 |
| KR20070046089A (ko) | 2007-05-02 |
| DE102004036437A1 (de) | 2006-03-23 |
| CA2570608A1 (en) | 2006-02-02 |
| BRPI0513904B8 (pt) | 2021-05-25 |
| BRPI0513904A (pt) | 2008-05-20 |
| JP2008508204A (ja) | 2008-03-21 |
| BRPI0513904B1 (pt) | 2019-02-05 |
| US8273375B2 (en) | 2012-09-25 |
| IL180943A (en) | 2010-12-30 |
| DE502005003223D1 (de) | 2008-04-24 |
| EP1771157A1 (de) | 2007-04-11 |
| JP5455305B2 (ja) | 2014-03-26 |
| EP1771157B1 (de) | 2008-03-12 |
| CA2570608C (en) | 2015-07-07 |
| WO2006010453A1 (de) | 2006-02-02 |
| KR101216750B1 (ko) | 2012-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL180943A0 (en) | Multiparticle pharmaceutical dosage form for a low-soluble active substances and method for producing said pharmaceutical dosage form | |
| IL173078A0 (en) | Multiparticle pharmaceutical dosage form containing a mucoadhesively formulated peptide or protein active substances method for producing said pharmaceutical dosage form | |
| HRP20120587T1 (hr) | Proizvodi otporni na neovlašteno otvaranje za primjenu opioida i ostalih lijekova pogodnih za zlouporabu | |
| HRP20161329T1 (hr) | Oralni oblici doziranja koji sadrže likarbazepin acetat | |
| WO2006039022A3 (en) | Controlled regional oral delivery | |
| NZ629468A (en) | Tamper resistant immediate release formulations | |
| MX2007006343A (es) | Forma farmaceutica multiparticulada que comprende ingredientes activos de acido nucleico mucoadhesivamente formulado y un proceso para producir la forma farmaceutica. | |
| EA200700049A1 (ru) | Препаративные формы оральных лекарственных форм мемантина с модифицированным высвобождением | |
| DE60036874D1 (de) | Pellet formulierung mit gesteuerter freisetzung | |
| EA201071054A1 (ru) | Твердый препарат, растворяющийся во рту | |
| YU58902A (sh) | Oralne formulacije opijatnog agonista otporne na mehaničke, termičke i/ili hemijske promene fizičkih osobina doznog oblika | |
| MX2008000099A (es) | Composiciones farmaceuticas de liberacion modificada novedosas, y procedimiento de preparacion de dichas composiciones. | |
| WO2006044049A3 (en) | Method of providing customized drug delivery systems | |
| BR0312347A (pt) | Composição farmacêutica oral, usos da espessura de revestimento de um material de revestimento dependente do ph de dissolução, de um material de revestimento, e de um material de polimetacrilato | |
| WO2006060681A3 (en) | Pharmaceutical composition containing an anti-nucleating agent | |
| MX2008001645A (es) | Composiciones de fexofendina en suspension farmaceutica oral. | |
| JP2008037863A (ja) | 不快味を呈する薬物含有製剤粒子 | |
| KR960021061A (ko) | 경구 투여용 약제학적 조성물 | |
| WO2006041843A3 (en) | Pharmaceutical dosage form comprising meloxicam | |
| WO2007120838A3 (en) | Rapidly disintegrating solid oral dosage form of liquid dispersions | |
| JP2016124800A (ja) | 生理活性物質含有造粒物及びその製造方法 | |
| UA80872C2 (uk) | Фармацевтична композиція, що містить як активну речовину платиновий комплекс, і спосіб її виготовлення | |
| WO1999042087A3 (en) | Controlled release potassium chloride pellet based pharmaceutical compositions having a high active ingredient content | |
| CN102349876A (zh) | 一种治疗胃溃疡和十二指肠溃疡的药物及其配制方法 | |
| JP2004535417A5 (pl) |